| Ausstehende Aktien | 61,458,046 shares |
| Insider-Aktien | 24.894.752 shares |
| Insider-Besitz | 40,51 % |
| Insider gesamt | 27 |
Insider-Stimmungswert
Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.
Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.
Aktualisierungshäufigkeit: Täglich
Führungskräfte-Stimmungswert
Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.
Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.
Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.
Aktualisierungshäufigkeit: Täglich
Wichtige Insider-Kennzahlen
Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.
Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).
Prozent des Streubesitzes von Insidern gekauft (Rang)
9781 out of 10791
Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.
Diagramm zum Insiderhandel
Cullinan Therapeutics, Inc. Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.
Kennzahlen zu Insiderlisten und Rentabilität
Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.
See our leaderboard of most profitable insider traders.
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Nadim Ahmed President and CEO, Director - [D] [O] | 390.803 | 390.803 | |
|
Bvf Partners L P/il
10% Owner -
|
64.161 | 64.161 | |
| Patrick Baeuerle Chief Scientific Officer - [O] | 417.434 | 417.434 | |
| Thomas Ebeling Director - [D] | 186.653 | 186.653 | |
|
Bioscience I 2017 Ltd F2
10% Owner -
|
537.392 | 537.392 | |
|
F2 Gc, Llc
10% Owner -
|
104.762 | 104.762 | |
|
Vision SCS F2
10% Owner -
|
4.476.350 | 4.476.350 | |
| Mary Kay Fenton Chief Financial Officer - [O] | 126.380 | 126.380 | |
|
Ansbert Gadicke
10% Owner -
|
595.489 | 595.489 |
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Owen Hughes President and CEO, Director - [D] [O] | 506.226 | 506.226 | |
| Jeffrey Alan Jones Chief Medical Officer - [O] | 159.968 | 159.968 | |
|
Morana Jovan-Embiricos
10% Owner -
|
207.803 | 4.476.350 | |
| Raymond T Keane Chief Legal Officer - [O] | 24.124 | 24.124 | |
|
Mark N Lampert
10% Owner -
|
319.415 | 64.161 | |
|
Lynx1 Capital Management LP
10% Owner -
|
8.963.500 | 8.963.500 | |
|
MPM Oncology Impact Management LP
10% Owner -
|
7.648.268 | 7.648.268 | |
| Anne-Marie Martin | 36.880 | ||
| Jennifer Michaelson Chief Scientific Officer - [O] | 166.844 | 166.844 |
| Insider | Durchschnittlicher Gewinn (%) | Aktien in Besitz |
Split Angepasst |
|---|---|---|---|
| Nate Nguyen Interim PAO and PFO - [O] | 13.375 | 13.375 | |
| Anthony Rosenberg Director - [D] | 45.002 | 45.002 | |
| Jacquelyn L Sumer Chief Legal Officer - [O] | 128.089 | 128.089 | |
| Corrine Savill Chief Business Officer - [O] | 240.990 | 240.990 | |
| Jeffrey Trigilio Chief Financial Officer - [O] | 133.919 | 133.919 | |
|
UBS Oncology Impact Fund L.P.
10% Owner -
|
7.648.268 | 7.648.268 | |
| Stephen W Webster | 7.800 | ||
| Jon Marc Wigginton | 116.666 | ||
| Leigh Zawel See Remarks - [O] | 69.785 | 69.785 |
Report errors via our new Insider Auditing Tool
Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse
In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in CGEM / Cullinan Therapeutics, Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse
In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in CGEM / Cullinan Therapeutics, Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .
Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.
Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.
Transaktionshistorie
Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.
| Datei Datum |
Handel Datum |
Form | Insider | Ticker | Wertpapier-Titel | Code | Direkt | Ausführung Preis |
Einheit Preis |
Eimheiten Verändert |
Wert Geändert (1K) |
Verbleibende Optionen |
Verbleibende Aktien |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-06 | 2026-05-05 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 15,5800 | -200 | -3 | 166.844 | ||||
| 2026-05-06 | 2026-05-05 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 14,6000 | -7.800 | -114 | 167.044 | ||||
| 2026-05-06 | 2026-05-05 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4,3000 | 4.000 | 17 | 174.844 | ||||
| 2026-03-09 | 2026-03-05 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 15,6800 | -8.000 | -125 | 170.844 | ||||
| 2026-03-09 | 2026-03-05 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4,3000 | 4.000 | 17 | 178.844 | ||||
| 2026-02-26 | 2026-02-25 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 14,1400 | -1.780 | -25 | 174.844 | ||||
| 2026-02-25 | 2026-02-24 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 14,4700 | -4.582 | -66 | 159.968 | ||||
| 2026-02-25 | 2026-02-24 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 14,4700 | -3.601 | -52 | 128.089 | ||||
| 2026-02-25 | 2026-02-24 | 4 | AHMED NADIM | CGEM | Common Stock | D | 14,4700 | -13.515 | -196 | 390.803 | ||||
| 2026-02-25 | 2026-02-24 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 14,4700 | -3.601 | -52 | 176.624 | ||||
| 2026-02-25 | 2026-02-23 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 13,9900 | -1.752 | -25 | 180.225 | ||||
| 2026-02-23 | 2026-02-20 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 13,6200 | -3.742 | -51 | 131.690 | ||||
| 2026-02-23 | 2026-02-20 | 4 | Fenton Mary Kay | CGEM | Common Stock | D | 13,6200 | -4.398 | -60 | 126.380 | ||||
| 2026-02-23 | 2026-02-20 | 4 | AHMED NADIM | CGEM | Common Stock | D | 13,6200 | -16.381 | -223 | 404.318 | ||||
| 2026-02-23 | 2026-02-20 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 14,3000 | -8.000 | -114 | 181.977 | ||||
| 2026-02-23 | 2026-02-20 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4,3000 | 8.000 | 34 | 189.977 | ||||
| 2026-02-23 | 2026-02-20 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 13,6200 | -3.742 | -51 | 181.977 | ||||
| 2026-02-23 | 2026-02-20 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 13,6200 | -4.982 | -68 | 164.550 | ||||
| 2026-02-19 | 2026-02-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 57.500 | 185.719 | ||||||
| 2026-02-19 | 2026-02-18 | 4 | Fenton Mary Kay | CGEM | Common Stock | D | 68.750 | 130.778 | ||||||
| 2026-02-13 | 2026-02-12 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 12,0300 | -416 | -5 | 128.219 | ||||
| 2026-01-23 | 2026-01-22 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 12,3000 | -4.000 | -49 | 128.635 | ||||
| 2026-01-05 | 2025-12-31 | 4 | Fenton Mary Kay | CGEM | Common Stock | D | 6,4900 | 27 | 0 | 62.028 | ||||
| 2025-12-29 | 2025-12-23 | 4 | AHMED NADIM | CGEM | Common Stock | D | 10,0100 | -9.922 | -99 | 420.699 | ||||
| 2025-12-22 | 2025-12-19 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 10,0100 | -1.345 | -13 | 132.635 | ||||
| 2025-12-19 | 2025-12-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 9,6700 | -2.898 | -28 | 133.980 | ||||
| 2025-12-19 | 2025-12-18 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 9,6700 | -4.632 | -45 | 169.532 | ||||
| 2025-12-19 | 2025-12-18 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 9,6700 | -3.480 | -34 | 135.432 | ||||
| 2025-12-16 | 2025-12-15 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 11,9000 | -995 | -12 | 136.878 | ||||
| 2025-12-16 | 2025-12-12 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 12,3800 | -2.148 | -27 | 137.873 | ||||
| 2025-11-25 | 2025-11-24 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 12,3000 | -4.000 | -49 | 138.004 | ||||
| 2025-10-30 | 2025-10-28 | 4 | Lynx1 Capital Management LP | CGEM | Common stock, $0.0001 par value per share | I | 8,4005 | 165.667 | 1.392 | 8.963.500 | ||||
| 2025-10-21 | 2025-10-17 | 4 | Lynx1 Capital Management LP | CGEM | Common Stock | I | 7,8395 | 32.217 | 253 | 8.797.833 | ||||
| 2025-10-21 | 2025-10-16 | 4 | Lynx1 Capital Management LP | CGEM | Common Stock | I | 8,8550 | 150.000 | 1.328 | 8.765.616 | ||||
| 2025-10-21 | 2025-10-15 | 4 | Lynx1 Capital Management LP | CGEM | Common Stock | I | 7,9427 | 51.500 | 409 | 8.615.616 | ||||
| 2025-10-21 | 2025-10-14 | 4 | Lynx1 Capital Management LP | CGEM | Common stock, $0.0001 par value per share ("Common Stock") | I | 7,5870 | 15.032 | 114 | 8.564.116 | ||||
| 2025-10-10 | 2025-10-10 | 4 | Lynx1 Capital Management LP | CGEM | Common Stock | I | 7,3617 | 277.298 | 2.041 | 8.549.084 | ||||
| 2025-10-10 | 2025-10-09 | 4 | Lynx1 Capital Management LP | CGEM | Common Stock | I | 6,6958 | 626.043 | 4.192 | 8.271.786 | ||||
| 2025-10-10 | 2025-10-08 | 4 | Lynx1 Capital Management LP | CGEM | Common stock, $0.0001 par value per share ("Common Stock") | I | 6,4600 | 556.300 | 3.594 | 7.645.743 | ||||
| 2025-10-10 | 3 | Lynx1 Capital Management LP | CGEM | Common stock, $0.0001 par value per share | I | 7.089.443 | ||||||||
| 2025-02-27 | 2025-02-25 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 8,5300 | -3.756 | -32 | 142.004 | ||||
| 2025-02-27 | 2025-02-25 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 8,5300 | -3.756 | -32 | 136.895 | ||||
| 2025-02-27 | 2025-02-25 | 4 | AHMED NADIM | CGEM | Common Stock | D | 8,5300 | -12.529 | -107 | 430.621 | ||||
| 2025-02-27 | 2025-02-25 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 8,5300 | -4.895 | -42 | 174.164 | ||||
| 2025-02-21 | 2025-02-19 | 4 | Fenton Mary Kay | CGEM | Common Stock | D | 60.000 | 60.000 | ||||||
| 2025-02-21 | 2025-02-19 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 65.000 | 179.059 | ||||||
| 2025-02-21 | 2025-02-19 | 4 | AHMED NADIM | CGEM | Common Stock | D | 180.000 | 443.150 | ||||||
| 2025-02-21 | 2025-02-19 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 50.000 | 140.651 | ||||||
| 2025-02-21 | 2025-02-19 | 4 | Savill Corrine | CGEM | Common Stock | D | 37.500 | 240.990 | ||||||
| 2025-02-21 | 2025-02-19 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 50.000 | 145.760 | ||||||
| 2025-01-07 | 2025-01-06 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 12,5100 | -4.000 | -50 | 95.760 | ||||
| 2024-12-27 | 2024-12-24 | 4 | AHMED NADIM | CGEM | Common Stock | D | 11,8700 | -8.400 | -100 | 263.150 | ||||
| 2024-12-20 | 2024-12-18 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 11,4100 | -3.482 | -40 | 90.651 | ||||
| 2024-12-20 | 2024-12-18 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 11,4100 | -4.632 | -53 | 114.059 | ||||
| 2024-12-20 | 2024-12-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 11,4100 | -4.693 | -54 | 99.760 | ||||
| 2024-12-16 | 2024-12-12 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 12,5200 | -3.489 | -44 | 104.453 | ||||
| 2024-11-07 | 2024-11-05 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 15,6400 | -8.000 | -125 | 107.942 | ||||
| 2024-09-09 | 2024-09-05 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 18,0900 | -8.000 | -145 | 115.942 | ||||
| 2024-07-09 | 2024-07-05 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 16,3300 | -8.000 | -131 | 123.942 | ||||
| 2024-07-02 | 2024-07-01 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 9,0000 | 2.360 | 21 | 131.942 | ||||
| 2024-06-11 | 2024-06-10 | 4 | Ebeling Thomas | CGEM | Common Stock | D | 13,0000 | 18.450 | 240 | 186.653 | ||||
| 2024-05-23 | 2024-05-23 | 4 | Ebeling Thomas | CGEM | Common Stock | D | 12,7300 | 16.475 | 210 | 168.203 | ||||
| 2024-05-23 | 2024-05-23 | 4 | Ebeling Thomas | CGEM | Common Stock | D | 4,3000 | 84.224 | 362 | 151.728 | ||||
| 2024-05-08 | 2024-05-07 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 30,0600 | -5.606 | -169 | 129.582 | ||||
| 2024-05-08 | 2024-05-07 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4,3000 | 5.606 | 24 | 135.188 | ||||
| 2024-05-08 | 2024-05-06 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 28,5400 | -20.277 | -579 | 129.582 | ||||
| 2024-05-08 | 2024-05-06 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 27,8200 | -37.723 | -1.049 | 149.859 | ||||
| 2024-05-08 | 2024-05-06 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4,3000 | 50.000 | 215 | 187.582 | ||||
| 2024-04-02 | 3 | Nguyen Nate | CGEM | Common Stock | D | 13.375 | ||||||||
| 2024-04-02 | 3 | Nguyen Nate | CGEM | Common Stock | D | 13.375 | ||||||||
| 2024-04-02 | 3 | Nguyen Nate | CGEM | Common Stock | D | 6.250 | ||||||||
| 2024-02-23 | 2024-02-22 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 50.000 | 137.582 | ||||||
| 2024-02-23 | 2024-02-22 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 62.500 | 118.691 | ||||||
| 2024-02-23 | 2024-02-22 | 4 | AHMED NADIM | CGEM | Common Stock | D | 160.000 | 271.550 | ||||||
| 2024-02-23 | 2024-02-22 | 4 | Savill Corrine | CGEM | Common Stock | D | 37.500 | 203.490 | ||||||
| 2024-02-23 | 2024-02-22 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 50.000 | 94.133 | ||||||
| 2024-02-23 | 2024-02-22 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 50.000 | 133.919 | ||||||
| 2024-02-02 | 2024-02-01 | 4 | Savill Corrine | CGEM | Common Stock | D | 16,1800 | -40.000 | -647 | 165.990 | ||||
| 2024-02-02 | 2024-02-01 | 4 | Savill Corrine | CGEM | Common Stock | D | 4,3000 | 40.000 | 172 | 205.990 | ||||
| 2024-01-30 | 2024-01-29 | 4 | Savill Corrine | CGEM | Common Stock | D | 14,0900 | -40.000 | -564 | 165.990 | ||||
| 2024-01-30 | 2024-01-29 | 4 | Savill Corrine | CGEM | Common Stock | D | 4,3000 | 40.000 | 172 | 205.990 | ||||
| 2024-01-24 | 2024-01-23 | 4 | Savill Corrine | CGEM | Common Stock | D | 12,4600 | -21.316 | -266 | 165.990 | ||||
| 2024-01-24 | 2024-01-23 | 4 | Savill Corrine | CGEM | Common Stock | D | 4,3000 | 21.316 | 92 | 187.306 | ||||
| 2024-01-24 | 2024-01-22 | 4 | Savill Corrine | CGEM | Common Stock | D | 12,0200 | -4.125 | -50 | 165.990 | ||||
| 2024-01-24 | 2024-01-22 | 4 | Savill Corrine | CGEM | Common Stock | D | 12,1800 | -14.559 | -177 | 170.115 | ||||
| 2024-01-24 | 2024-01-22 | 4 | Savill Corrine | CGEM | Common Stock | D | 4,3000 | 14.559 | 63 | 184.674 | ||||
| 2023-12-27 | 2023-12-26 | 4 | AHMED NADIM | CGEM | Common Stock | D | 9,2400 | -4.272 | -39 | 111.550 | ||||
| 2023-12-22 | 2023-12-21 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 8,5000 | -1.400 | -12 | 44.133 | ||||
| 2023-12-22 | 2023-12-21 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 8,5000 | -1.860 | -16 | 56.191 | ||||
| 2023-12-22 | 2023-12-21 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 8,5000 | -1.920 | -16 | 83.919 | ||||
| 2023-12-22 | 2023-12-21 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 8,5000 | -1.145 | -10 | 87.582 | ||||
| 2023-12-20 | 2023-12-18 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 8,2200 | -290 | -2 | 45.533 | ||||
| 2023-12-20 | 2023-12-18 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 8,2200 | -398 | -3 | 85.839 | ||||
| 2023-12-20 | 2023-12-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 8,2200 | -238 | -2 | 88.727 | ||||
| 2023-12-20 | 2023-12-18 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 8,2200 | -386 | -3 | 58.051 | ||||
| 2023-12-13 | 2023-12-12 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 7,8100 | -1.068 | -8 | 88.965 | ||||
| 2023-12-13 | 2023-12-12 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 7,8100 | -1.926 | -15 | 86.237 | ||||
| 2023-07-05 | 2023-06-30 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 9,0800 | 2.340 | 21 | 88.163 | ||||
| 2023-06-29 | 2023-06-28 | 4 | AHMED NADIM | CGEM | Common Stock | D | 11,4000 | -759 | -9 | 115.822 | ||||
| 2023-06-21 | 2023-06-20 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 12,9400 | -399 | -5 | 85.823 | ||||
| 2023-06-21 | 2023-06-20 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 12,9400 | -291 | -4 | 45.823 | ||||
| 2023-06-21 | 2023-06-20 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 12,9400 | -238 | -3 | 90.033 | ||||
| 2023-06-21 | 2023-06-20 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 12,9400 | -387 | -5 | 58.437 | ||||
| 2023-06-14 | 2023-06-12 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 13,1100 | -176 | -2 | 90.271 | ||||
| 2023-06-14 | 2023-06-12 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 13,1100 | -319 | -4 | 86.222 | ||||
| 2023-06-08 | 2023-06-07 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 12,4000 | -100 | -1 | 90.447 | ||||
| 2023-06-08 | 2023-06-07 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4,3000 | 100 | 0 | 90.547 | ||||
| 2023-06-08 | 2023-06-06 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 12,3100 | -11.900 | -146 | 90.447 | ||||
| 2023-06-08 | 2023-06-06 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4,3000 | 11.900 | 51 | 102.347 | ||||
| 2023-05-24 | 2023-05-23 | 4 | AHMED NADIM | CGEM | Common Stock | D | 9,1500 | -707 | -6 | 116.581 | ||||
| 2023-05-19 | 2023-05-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 8,7600 | -239 | -2 | 90.447 | ||||
| 2023-05-19 | 2023-05-18 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 8,7600 | -394 | -3 | 58.824 | ||||
| 2023-05-19 | 2023-05-18 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 8,7600 | -399 | -3 | 86.541 | ||||
| 2023-05-19 | 2023-05-18 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 8,7600 | -291 | -3 | 46.114 | ||||
| 2023-05-16 | 2023-05-12 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 8,7800 | -193 | -2 | 90.686 | ||||
| 2023-05-16 | 2023-05-12 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 8,7800 | -347 | -3 | 86.940 | ||||
| 2023-04-26 | 2023-04-25 | 4 | AHMED NADIM | CGEM | Common Stock | D | 10,5900 | -716 | -8 | 117.288 | ||||
| 2023-04-20 | 2023-04-18 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 10,7100 | -392 | -4 | 59.218 | ||||
| 2023-04-20 | 2023-04-18 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 10,7100 | -398 | -4 | 87.287 | ||||
| 2023-04-20 | 2023-04-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 10,7100 | -238 | -3 | 90.879 | ||||
| 2023-04-20 | 2023-04-18 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 10,7100 | -290 | -3 | 46.405 | ||||
| 2023-04-14 | 2023-04-12 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 10,2200 | -318 | -3 | 87.685 | ||||
| 2023-04-14 | 2023-04-12 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 10,2200 | -176 | -2 | 91.117 | ||||
| 2023-03-27 | 2023-03-20 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 11,3200 | -238 | -3 | 91.293 | ||||
| 2023-03-27 | 2023-03-23 | 4 | AHMED NADIM | CGEM | Common Stock | D | 10,5100 | -706 | -7 | 118.004 | ||||
| 2023-03-27 | 2023-03-20 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 11,3200 | -390 | -4 | 59.610 | ||||
| 2023-03-27 | 2023-03-20 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 11,3200 | -305 | -3 | 46.695 | ||||
| 2023-03-27 | 2023-03-20 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 11,3200 | -399 | -5 | 88.003 | ||||
| 2023-02-23 | 2023-02-22 | 4 | AHMED NADIM | CGEM | Common Stock | D | 109.000 | 118.710 | ||||||
| 2023-02-21 | 2023-02-17 | 4 | Baeuerle Patrick | CGEM | Common Stock | D | 38.500 | 76.000 | ||||||
| 2023-02-21 | 2023-02-17 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 47.000 | 88.402 | ||||||
| 2023-02-21 | 2023-02-17 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 47.000 | 47.000 | ||||||
| 2023-02-21 | 2023-02-17 | 4 | Savill Corrine | CGEM | Common Stock | D | 20.500 | 170.115 | ||||||
| 2023-02-21 | 2023-02-17 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 38.500 | 91.531 | ||||||
| 2023-02-21 | 2023-02-17 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 60.000 | 60.000 | ||||||
| 2023-02-10 | 2021-12-21 | 5 | GADICKE ANSBERT | CGEM | Common Stock | D | 4,3000 | 350.938 | 1.509 | 595.489 | ||||
| 2023-01-19 | 2023-01-19 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | -300.000 | 64.161 | ||||||
| 2023-01-19 | 2023-01-19 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | -2.600.000 | 392.808 | ||||||
| 2023-01-19 | 2023-01-19 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | -3.500.000 | 558.854 | ||||||
| 2023-01-06 | 2022-12-30 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 8,9700 | 201 | 2 | 41.402 | ||||
| 2022-11-29 | 2022-11-25 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 13,3000 | -4.000 | -53 | 53.031 | ||||
| 2022-11-29 | 2022-11-25 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4,3000 | 4.000 | 17 | 57.031 | ||||
| 2022-09-29 | 2022-09-27 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 12,4000 | -4.000 | -50 | 53.031 | ||||
| 2022-09-29 | 2022-09-27 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4,3000 | 4.000 | 17 | 57.031 | ||||
| 2022-08-09 | 2022-08-08 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 15,0100 | -1.385 | -21 | 53.031 | ||||
| 2022-08-09 | 2022-08-08 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4,3000 | 1.385 | 6 | 54.416 | ||||
| 2022-08-04 | 2022-08-04 | 4 | F2 Vision SCS | CGEM | Common Stock | D | 14,3056 | -25.989 | -372 | 1.255.963 | ||||
| 2022-08-04 | 2022-08-03 | 4 | F2 Vision SCS | CGEM | Common Stock | D | 14,2367 | -19.129 | -272 | 1.281.952 | ||||
| 2022-08-04 | 2022-08-02 | 4 | F2 Vision SCS | CGEM | Common Stock | D | 14,0973 | -4.792 | -68 | 1.301.081 | ||||
| 2022-07-26 | 2022-07-25 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 14,5100 | -8.000 | -116 | 53.031 | ||||
| 2022-07-26 | 2022-07-25 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4,3000 | 8.000 | 34 | 61.031 | ||||
| 2022-07-21 | 2022-07-19 | 4 | Savill Corrine | CGEM | Common Stock | D | 15,2200 | -14.958 | -228 | 149.615 | ||||
| 2022-07-21 | 2022-07-18 | 4 | Savill Corrine | CGEM | Common Stock | D | 15,0600 | -5.042 | -76 | 164.573 | ||||
| 2022-07-12 | 2022-07-11 | 4 | Savill Corrine | CGEM | Common Stock | D | 13,8500 | -200 | -3 | 169.615 | ||||
| 2022-07-12 | 2022-07-11 | 4 | Savill Corrine | CGEM | Common Stock | D | 13,3300 | -39.800 | -531 | 169.815 | ||||
| 2022-07-05 | 2022-06-30 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 10,9000 | 1.620 | 18 | 53.031 | ||||
| 2022-07-05 | 2022-06-30 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 10,9000 | 1.451 | 16 | 41.201 | ||||
| 2022-07-05 | 2022-06-30 | 4 | AHMED NADIM | CGEM | Common Stock | D | 10,9000 | 1.620 | 18 | 9.710 | ||||
| 2022-06-28 | 2022-06-24 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | D | 13,3900 | -45.078 | -604 | 207.803 | ||||
| 2022-06-28 | 2022-06-24 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | D | 4,3000 | 35.529 | 153 | 252.881 | ||||
| 2022-06-28 | 2022-06-24 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | D | 4,3000 | 104.845 | 451 | 217.352 | ||||
| 2022-06-23 | 2022-06-23 | 4 | F2 Bioscience I 2017 Ltd | CGEM | Common Stock | D | 13,0036 | -29.631 | -385 | 537.392 | ||||
| 2022-06-23 | 2022-06-22 | 4 | F2 Bioscience I 2017 Ltd | CGEM | Common Stock | D | 12,7035 | -49.953 | -635 | 567.023 | ||||
| 2022-06-23 | 2022-06-21 | 4 | F2 Bioscience I 2017 Ltd | CGEM | Common Stock | D | 12,7662 | -22.319 | -285 | 616.976 | ||||
| 2022-06-07 | 2022-06-06 | 4 | AHMED NADIM | CGEM | Common Stock | D | 12,4000 | 8.090 | 100 | 8.090 | ||||
| 2022-06-03 | 2022-06-01 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | 10,9994 | 44.746 | 492 | 364.161 | ||||
| 2022-06-03 | 2022-06-01 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | 10,9994 | 301.009 | 3.311 | 2.992.808 | ||||
| 2022-06-03 | 2022-06-01 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | 10,9994 | 405.641 | 4.462 | 4.058.854 | ||||
| 2022-05-16 | 2022-05-16 | 4 | F2 Vision SCS | CGEM | Common Stock | D | 11,2301 | -35.158 | -395 | 1.305.873 | ||||
| 2022-05-16 | 2022-05-13 | 4 | F2 Vision SCS | CGEM | Common Stock | D | 10,4810 | -34.189 | -358 | 1.341.031 | ||||
| 2022-05-16 | 2022-05-13 | 4 | F2 Vision SCS | CGEM | Common Stock | D | 9,9631 | -85.319 | -850 | 1.375.220 | ||||
| 2022-05-16 | 2022-05-12 | 4 | F2 Vision SCS | CGEM | Common Stock | D | 9,2497 | -264.072 | -2.443 | 1.460.539 | ||||
| 2022-05-16 | 2022-05-13 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | 9,1350 | 17.744 | 162 | 319.415 | ||||
| 2022-05-16 | 2022-05-13 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | 9,1350 | 38.558 | 352 | 2.691.799 | ||||
| 2022-05-16 | 2022-05-13 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | 9,1350 | 53.598 | 490 | 3.653.213 | ||||
| 2022-05-16 | 2022-05-12 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | 9,0600 | 457.001 | 4.140 | 2.653.241 | ||||
| 2022-05-16 | 2022-05-12 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | 9,0600 | 542.999 | 4.920 | 3.599.615 | ||||
| 2022-04-05 | 2022-04-01 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | 10,7499 | 9.402 | 101 | 2.196.240 | ||||
| 2022-04-05 | 2022-04-01 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | 10,7499 | 266.598 | 2.866 | 3.056.616 | ||||
| 2022-03-25 | 2021-09-16 | 4 | Ebeling Thomas | CGEM | Stock Option (Right to Buy) | D | 28,80 | 7.800 | 7.800 | |||||
| 2022-03-25 | 2021-09-16 | 4 | Rosenberg Anthony | CGEM | Stock Option (Right to Buy) | D | 28,80 | 7.800 | 7.800 | |||||
| 2022-03-25 | 2021-09-16 | 4 | Webster Stephen W | CGEM | Stock Option (Right to Buy) | D | 28,80 | 7.800 | 7.800 | |||||
| 2022-03-25 | 2021-09-16 | 4 | Jovan-Embiricos Morana | CGEM | Stock Option (Right to Buy) | D | 28,80 | 7.800 | 7.800 | |||||
| 2022-03-25 | 2021-09-16 | 4 | GADICKE ANSBERT | CGEM | Stock Option (Right to Buy) | D | 28,80 | 7.800 | 7.800 | |||||
| 2022-03-07 | 2022-03-05 | 4 | AHMED NADIM | CGEM | Performance Stock Unit | D | 215.000 | 215.000 | ||||||
| 2022-03-02 | 2022-03-01 | 4 | Martin Anne-Marie | CGEM | Stock Option (Right to Buy) | D | 13,99 | 36.880 | 36.880 | |||||
| 2022-03-02 | 2022-02-28 | 4 | Jones Jeffrey Alan | CGEM | Stock Option (Right to Buy) | D | 14,34 | 215.000 | 215.000 | |||||
| 2022-02-15 | 2022-02-11 | 4 | Michaelson Jennifer | CGEM | Stock Option (Right to Buy) | D | 13,60 | 57.000 | 57.000 | |||||
| 2022-02-15 | 2022-02-11 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 28.500 | 51.411 | ||||||
| 2022-02-15 | 2022-02-11 | 4 | Keane Raymond T | CGEM | Stock Option (Right to Buy) | D | 13,60 | 45.000 | 45.000 | |||||
| 2022-02-15 | 2022-02-11 | 4 | Keane Raymond T | CGEM | Common Stock | D | 22.500 | 24.124 | ||||||
| 2022-02-15 | 2022-02-11 | 4 | Zawel Leigh | CGEM | Stock Option (Right to Buy) | D | 13,60 | 65.000 | 65.000 | |||||
| 2022-02-15 | 2022-02-11 | 4 | Zawel Leigh | CGEM | Common Stock | D | 32.500 | 69.785 | ||||||
| 2022-02-15 | 2022-02-11 | 4 | Baeuerle Patrick | CGEM | Stock Option (Right to Buy) | D | 13,60 | 75.000 | 75.000 | |||||
| 2022-02-15 | 2022-02-11 | 4 | Baeuerle Patrick | CGEM | Common Stock | D | 37.500 | 37.500 | ||||||
| 2022-02-15 | 2022-02-11 | 4 | Trigilio Jeffrey | CGEM | Stock Option (Right to Buy) | D | 13,60 | 75.000 | 75.000 | |||||
| 2022-02-15 | 2022-02-11 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 37.500 | 39.750 | ||||||
| 2022-02-15 | 2022-02-11 | 4 | Savill Corrine | CGEM | Stock Option (Right to Buy) | D | 13,60 | 33.000 | 33.000 | |||||
| 2022-02-15 | 2022-02-11 | 4 | Savill Corrine | CGEM | Common Stock | D | 16.500 | 209.615 | ||||||
| 2022-01-13 | 2022-01-11 | 4 | F2 Vision SCS | CGEM | Common Stock | D | -1.187.734 | 1.724.611 | ||||||
| 2022-01-10 | 3 | LAMPERT MARK N | CGEM | Common Stock | D | 301.671 | ||||||||
| 2022-01-10 | 3 | LAMPERT MARK N | CGEM | Common Stock | D | 2.186.838 | ||||||||
| 2022-01-10 | 3 | LAMPERT MARK N | CGEM | Common Stock | D | 2.790.018 | ||||||||
| 2021-10-20 | 2021-10-18 | 4 | AHMED NADIM | CGEM | Stock Option (Right to Buy) | D | 21,12 | 2.710.000 | 2.710.000 | |||||
| 2021-10-20 | 2021-10-18 | 4 | Michaelson Jennifer | CGEM | Stock Option (Right to Buy) | D | 4,30 | -4.000 | 217.978 | |||||
| 2021-10-20 | 2021-10-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 23,6100 | -400 | -9 | 22.911 | ||||
| 2021-10-20 | 2021-10-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 22,4000 | -204 | -5 | 23.311 | ||||
| 2021-10-20 | 2021-10-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 21,1000 | -3.396 | -72 | 23.515 | ||||
| 2021-10-20 | 2021-10-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4,3000 | 4.000 | 17 | 26.911 | ||||
| 2021-10-18 | 2021-10-15 | 4 | Zawel Leigh | CGEM | Common Stock | D | 25,0000 | -19.574 | -489 | 37.285 | ||||
| 2021-10-18 | 2021-10-15 | 4 | Trigilio Jeffrey | CGEM | Stock Option (Right to Buy) | D | 4,30 | -8.000 | 229.891 | |||||
| 2021-10-18 | 2021-10-15 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 25,0000 | -8.000 | -200 | 2.250 | ||||
| 2021-10-18 | 2021-10-15 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 4,3000 | 8.000 | 34 | 10.250 | ||||
| 2021-10-12 | 2021-10-07 | 4 | Zawel Leigh | CGEM | Common Stock | D | 25,0000 | -1.079 | -27 | 56.859 | ||||
| 2021-09-21 | 2021-09-20 | 4 | Michaelson Jennifer | CGEM | Stock Option (Right to Buy) | D | 4,30 | -4.000 | 221.978 | |||||
| 2021-09-21 | 2021-09-20 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 25,2000 | -800 | -20 | 22.911 | ||||
| 2021-09-21 | 2021-09-20 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 24,3400 | -3.200 | -78 | 23.711 | ||||
| 2021-09-21 | 2021-09-20 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4,3000 | 4.000 | 17 | 26.911 | ||||
| 2021-09-21 | 2021-09-20 | 4 | Zawel Leigh | CGEM | Common Stock | D | 25,1600 | -7.468 | -188 | 57.938 | ||||
| 2021-09-20 | 2021-09-16 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29,0600 | -3.124 | -91 | 7.648.268 | ||||
| 2021-09-20 | 2021-09-16 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29,0600 | -3.124 | -91 | 7.648.268 | ||||
| 2021-09-20 | 2021-09-16 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29,0600 | -432 | -13 | 244.551 | ||||
| 2021-09-16 | 2021-09-15 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29,1600 | -6.425 | -187 | 7.651.392 | ||||
| 2021-09-16 | 2021-09-14 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29,1700 | -7.106 | -207 | 7.657.817 | ||||
| 2021-09-16 | 2021-09-15 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29,1600 | -6.425 | -187 | 7.651.392 | ||||
| 2021-09-16 | 2021-09-15 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29,1600 | -888 | -26 | 244.983 | ||||
| 2021-09-16 | 2021-09-14 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29,1700 | -7.106 | -207 | 7.657.817 | ||||
| 2021-09-16 | 2021-09-14 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29,1700 | -982 | -29 | 245.871 | ||||
| 2021-09-13 | 2021-09-13 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29,1000 | -3.595 | -105 | 7.664.923 | ||||
| 2021-09-13 | 2021-09-10 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29,0400 | -5.931 | -172 | 7.668.518 | ||||
| 2021-09-13 | 2021-09-09 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29,3500 | -13.727 | -403 | 7.674.449 | ||||
| 2021-09-13 | 2021-09-13 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29,1000 | -3.595 | -105 | 7.664.923 | ||||
| 2021-09-13 | 2021-09-13 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29,1000 | -497 | -14 | 246.853 | ||||
| 2021-09-13 | 2021-09-10 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29,0400 | -5.931 | -172 | 7.668.518 | ||||
| 2021-09-13 | 2021-09-10 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29,0400 | -820 | -24 | 247.350 | ||||
| 2021-09-13 | 2021-09-09 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29,3500 | -13.727 | -403 | 7.674.449 | ||||
| 2021-09-13 | 2021-09-09 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29,3500 | -1.898 | -56 | 248.170 | ||||
| 2021-09-09 | 2021-09-08 | 4 | Baeuerle Patrick | CGEM | Stock Option (Right to Buy) | D | 4,30 | -11.000 | 240.114 | |||||
| 2021-09-09 | 2021-09-08 | 4 | Baeuerle Patrick | CGEM | Common Stock | D | 28,4500 | -11.000 | -313 | 0 | ||||
| 2021-09-09 | 2021-09-08 | 4 | Baeuerle Patrick | CGEM | Common Stock | D | 4,3000 | 11.000 | 47 | 11.000 | ||||
| 2021-09-09 | 2021-09-08 | 4 | Trigilio Jeffrey | CGEM | Stock Option (Right to Buy) | D | 4,30 | -15.000 | 237.891 | |||||
| 2021-09-09 | 2021-09-08 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 28,8500 | -9.513 | -274 | 2.250 | ||||
| 2021-09-09 | 2021-09-08 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 27,8300 | -5.487 | -153 | 11.763 | ||||
| 2021-09-09 | 2021-09-08 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 4,3000 | 15.000 | 64 | 17.250 | ||||
| 2021-09-08 | 2021-09-08 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29,1100 | -10.842 | -316 | 7.688.176 | ||||
| 2021-09-08 | 2021-09-07 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29,0400 | -25.067 | -728 | 7.699.018 | ||||
| 2021-09-08 | 2021-09-03 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29,6000 | -12.731 | -377 | 7.724.085 | ||||
| 2021-09-08 | 2021-09-08 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29,1100 | -10.842 | -316 | 7.688.176 | ||||
| 2021-09-08 | 2021-09-08 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29,1100 | -1.499 | -44 | 250.068 | ||||
| 2021-09-08 | 2021-09-07 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29,0400 | -25.067 | -728 | 7.699.018 | ||||
| 2021-09-08 | 2021-09-07 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29,0400 | -3.465 | -101 | 251.567 | ||||
| 2021-09-08 | 2021-09-03 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29,6000 | -12.731 | -377 | 7.724.085 | ||||
| 2021-09-08 | 2021-09-03 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29,6000 | -1.760 | -52 | 255.032 | ||||
| 2021-09-08 | 2021-09-07 | 4 | Zawel Leigh | CGEM | Common Stock | D | 28,9500 | -28.118 | -814 | 65.406 | ||||
| 2021-09-02 | 2021-09-02 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29,4600 | -15.757 | -464 | 7.736.816 | ||||
| 2021-09-02 | 2021-09-01 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29,4700 | -5.714 | -168 | 7.752.573 | ||||
| 2021-09-02 | 2021-08-31 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 30,1400 | -1.553 | -47 | 7.758.287 | ||||
| 2021-09-02 | 2021-08-31 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29,4300 | -1.285 | -38 | 7.759.840 | ||||
| 2021-09-02 | 2021-09-02 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29,4600 | -15.757 | -464 | 7.736.816 | ||||
| 2021-09-02 | 2021-09-02 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29,4600 | -2.178 | -64 | 256.792 | ||||
| 2021-09-02 | 2021-09-01 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29,4700 | -5.714 | -168 | 7.752.573 | ||||
| 2021-09-02 | 2021-09-01 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29,4700 | -790 | -23 | 258.970 | ||||
| 2021-09-02 | 2021-08-31 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 30,1400 | -1.553 | -47 | 7.758.287 | ||||
| 2021-09-02 | 2021-08-31 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 30,1400 | -215 | -6 | 259.760 | ||||
| 2021-09-02 | 2021-08-31 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29,4300 | -1.285 | -38 | 7.759.840 | ||||
| 2021-09-02 | 2021-08-31 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29,4300 | -177 | -5 | 259.975 | ||||
| 2021-08-31 | 2021-08-30 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29,3000 | -31.001 | -908 | 7.761.125 | ||||
| 2021-08-31 | 2021-08-30 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29,3000 | -4.285 | -126 | 260.152 | ||||
| 2021-08-31 | 2021-08-27 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29,0900 | -13.357 | -389 | 7.792.126 | ||||
| 2021-08-31 | 2021-08-27 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29,0900 | -1.846 | -54 | 264.437 | ||||
| 2021-08-31 | 2021-08-30 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29,3000 | -31.001 | -908 | 7.761.125 | ||||
| 2021-08-31 | 2021-08-27 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29,0900 | -13.357 | -389 | 7.792.126 | ||||
| 2021-08-26 | 2021-08-10 | 4/A | Zawel Leigh | CGEM | Common Stock | D | 28,4900 | -1.817 | -52 | 121.642 | ||||
| 2021-08-26 | 2021-08-10 | 4/A | Zawel Leigh | CGEM | Common Stock | D | 27,3400 | -3.191 | -87 | 123.459 | ||||
| 2021-08-26 | 2021-08-10 | 4/A | Zawel Leigh | CGEM | Common Stock | D | 26,5000 | -1.906 | -51 | 126.650 | ||||
| 2021-08-26 | 2021-08-09 | 4/A | Zawel Leigh | CGEM | Common Stock | D | 27,1100 | -1.700 | -46 | 128.556 | ||||
| 2021-08-26 | 2021-08-09 | 4/A | Zawel Leigh | CGEM | Common Stock | D | 26,5200 | -19.504 | -517 | 130.256 | ||||
| 2021-08-26 | 2021-08-23 | 4/A | Zawel Leigh | CGEM | Common Stock | D | 29,0000 | -28.118 | -815 | 93.524 | ||||
| 2021-08-26 | 2021-08-18 | 4/A | Michaelson Jennifer | CGEM | Stock Option (Right to Buy) | D | 4,30 | -4.000 | 225.978 | |||||
| 2021-08-26 | 2021-08-18 | 4/A | Michaelson Jennifer | CGEM | Common Stock | D | 28,0700 | -1.137 | -32 | 22.911 | ||||
| 2021-08-26 | 2021-08-18 | 4/A | Michaelson Jennifer | CGEM | Common Stock | D | 27,5000 | -2.863 | -79 | 24.048 | ||||
| 2021-08-26 | 2021-08-18 | 4/A | Michaelson Jennifer | CGEM | Common Stock | D | 4,3000 | 4.000 | 17 | 26.911 | ||||
| 2021-08-26 | 2021-08-10 | 4 | Baeuerle Patrick | CGEM | Stock Option (Right to Buy) | D | 4,30 | -11.000 | 251.114 | |||||
| 2021-08-26 | 2021-08-10 | 4 | Baeuerle Patrick | CGEM | Common Stock | D | 27,0000 | -11.000 | -297 | 0 | ||||
| 2021-08-26 | 2021-08-10 | 4 | Baeuerle Patrick | CGEM | Common Stock | D | 4,3000 | 11.000 | 47 | 11.000 | ||||
| 2021-08-25 | 2021-08-25 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29,0900 | -1.713 | -50 | 7.805.483 | ||||
| 2021-08-25 | 2021-08-24 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29,4800 | -50.822 | -1.498 | 7.807.196 | ||||
| 2021-08-25 | 2021-08-23 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29,1100 | -53.359 | -1.553 | 7.858.018 | ||||
| 2021-08-25 | 2021-08-25 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29,0900 | -1.713 | -50 | 7.805.483 | ||||
| 2021-08-25 | 2021-08-25 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29,0900 | -237 | -7 | 266.283 | ||||
| 2021-08-25 | 2021-08-24 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29,4800 | -50.882 | -1.500 | 7.807.196 | ||||
| 2021-08-25 | 2021-08-24 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29,4800 | -7.025 | -207 | 266.520 | ||||
| 2021-08-25 | 2021-08-23 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29,1100 | -53.359 | -1.553 | 7.858.018 | ||||
| 2021-08-25 | 2021-08-23 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29,1100 | -7.376 | -215 | 273.545 | ||||
| 2021-08-24 | 2021-08-18 | 4 | Michaelson Jennifer | CGEM | Stock Option (Right to Buy) | D | 4,30 | -4.000 | 225.978 | |||||
| 2021-08-24 | 2021-08-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 28,0700 | -1.137 | -32 | 22.911 | ||||
| 2021-08-24 | 2021-08-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 27,5000 | -2.863 | -79 | 24.048 | ||||
| 2021-08-24 | 2021-08-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4,3000 | 4.000 | 17 | 26.911 | ||||
| 2021-08-24 | 2021-08-23 | 4 | Zawel Leigh | CGEM | Common Stock | D | 29,0000 | -28.118 | -815 | 93.524 | ||||
| 2021-08-12 | 2021-08-11 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29,0500 | -2.510 | -73 | 7.911.377 | ||||
| 2021-08-12 | 2021-08-11 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29,0500 | -2.510 | -73 | 7.911.377 | ||||
| 2021-08-12 | 2021-08-11 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29,0500 | -347 | -10 | 280.921 | ||||
| 2021-08-11 | 2021-08-10 | 4 | Zawel Leigh | CGEM | Common Stock | D | 28,4900 | -1.817 | -52 | 121.642 | ||||
| 2021-08-11 | 2021-08-10 | 4 | Zawel Leigh | CGEM | Common Stock | D | 27,3400 | -3.191 | -87 | 123.459 | ||||
| 2021-08-11 | 2021-08-10 | 4 | Zawel Leigh | CGEM | Common Stock | D | 26,5000 | -1.906 | -51 | 126.650 | ||||
| 2021-08-11 | 2021-08-09 | 4 | Zawel Leigh | CGEM | Common Stock | D | 27,1100 | -1.700 | -46 | 128.556 | ||||
| 2021-08-11 | 2021-08-09 | 4 | Zawel Leigh | CGEM | Common Stock | D | 26,5200 | -19.504 | -517 | 130.256 | ||||
| 2021-01-14 | 2021-01-12 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Series C Convertible Preferred Stock | D | -649.030 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Series B Convertible Preferred Stock | D | -2.276.692 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Series A Convertible Preferred Stock | D | -3.551.640 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Series Seed Convertible Preferred Stock | D | -1.136.525 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 21,0000 | 300.000 | 6.300 | 7.913.887 | ||||
| 2021-01-14 | 2021-01-12 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 649.030 | 7.613.887 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 2.276.692 | 6.964.857 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 3.551.640 | 4.688.165 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 1.136.525 | 1.136.525 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | GADICKE ANSBERT See footnotes | CGEM | Series C Convertible Preferred Stock | I | -649.030 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | GADICKE ANSBERT See footnotes | CGEM | Series B Convertible Preferred Stock | I | -2.276.692 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | GADICKE ANSBERT See footnotes | CGEM | Series A Convertible Preferred Stock | I | -3.551.640 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | GADICKE ANSBERT See footnotes | CGEM | Series Seed Convertible Preferred Stock | I | -1.136.525 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | GADICKE ANSBERT See footnotes | CGEM | Common Stock | I | 21,0000 | 300.000 | 6.300 | 7.913.887 | ||||
| 2021-01-14 | 2021-01-12 | 4 | GADICKE ANSBERT See footnotes | CGEM | Common Stock | I | 649.030 | 7.613.887 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | GADICKE ANSBERT See footnotes | CGEM | Common Stock | I | 2.276.692 | 6.964.857 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | GADICKE ANSBERT See footnotes | CGEM | Common Stock | I | 3.551.640 | 4.688.165 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | GADICKE ANSBERT See footnotes | CGEM | Common Stock | I | 1.136.525 | 1.136.525 | ||||||
| 2021-01-14 | 2021-01-07 | 4 | GADICKE ANSBERT | CGEM | Stock Option (Right to Buy) | D | 4,30 | 88.824 | 88.824 | |||||
| 2021-01-14 | 2021-01-07 | 4 | GADICKE ANSBERT | CGEM | Stock Option (Right to Buy) | D | 4,30 | 262.114 | 262.114 | |||||
| 2021-01-14 | 2021-01-07 | 4 | GADICKE ANSBERT See footnotes | CGEM | Series C Convertible Preferred Stock | I | 649.030 | 649.030 | ||||||
| 2021-01-14 | 2021-01-07 | 4 | GADICKE ANSBERT See footnotes | CGEM | Series B Convertible Preferred Stock | I | 2.276.692 | 2.276.692 | ||||||
| 2021-01-14 | 2021-01-07 | 4 | GADICKE ANSBERT See footnotes | CGEM | Series A Convertible Preferred Stock | I | 3.551.640 | 3.551.640 | ||||||
| 2021-01-14 | 2021-01-07 | 4 | GADICKE ANSBERT See footnotes | CGEM | Series Seed Convertible Preferred Stock | I | 1.136.525 | 1.136.525 | ||||||
| 2021-01-14 | 2021-01-07 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 281.268 | 281.268 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Series C Convertible Preferred Stock | I | -1.511.966 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Series C Convertible Preferred Stock | I | -503.988 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Series C Convertible Preferred Stock | I | -503.988 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Series C Convertible Preferred Stock | I | -1.007.977 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Series B Convertible Preferred Stock | I | -1.282.051 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Series B Convertible Preferred Stock | I | -3.205.128 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Series A Convertible Preferred Stock | I | -4.500.000 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Series A Convertible Preferred Stock | I | -20.500.000 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Series Seed Convertible Preferred Stock | I | -8.000.000 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | I | 21,0000 | 104.762 | 2.200 | 104.762 | ||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | I | 21,0000 | 95.238 | 2.000 | 622.175 | ||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | I | 214.798 | 214.798 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | I | 71.599 | 71.599 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | I | 71.599 | 71.599 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | I | 143.198 | 325.333 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | I | 182.135 | 182.135 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | I | 455.338 | 455.338 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | I | 639.295 | 639.295 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | I | 2.912.345 | 2.912.345 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | I | 1.136.525 | 1.136.525 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 21,0000 | 2.250 | 47 | 2.250 | ||||
| 2021-01-14 | 2021-01-12 | 4 | Hughes Owen | CGEM | Common Stock | D | 21,0000 | 2.500 | 52 | 506.226 | ||||
| 2021-01-11 | 2021-01-07 | 4 | Baeuerle Patrick | CGEM | Stock Option (Right to Buy) | D | 21,00 | 286.665 | 286.665 | |||||
| 2021-01-11 | 2021-01-07 | 4 | Zawel Leigh | CGEM | Stock Option (Right to Buy) | D | 21,00 | 56.666 | 56.666 | |||||
| 2021-01-11 | 2021-01-07 | 4 | Michaelson Jennifer | CGEM | Stock Option (Right to Buy) | D | 21,00 | 79.999 | 79.999 | |||||
| 2021-01-11 | 2021-01-07 | 4 | Hughes Owen | CGEM | Stock Option (Right to Buy) | D | 21,00 | 433.332 | 433.332 | |||||
| 2021-01-11 | 2021-01-07 | 4 | Trigilio Jeffrey | CGEM | Stock Option (Right to Buy) | D | 21,00 | 146.665 | 146.665 | |||||
| 2021-01-11 | 2021-01-07 | 4 | Wigginton Jon Marc | CGEM | Stock Option (Right to Buy) | D | 21,00 | 116.666 | 116.666 | |||||
| 2021-01-11 | 2021-01-07 | 4 | Keane Raymond T | CGEM | Stock Option (Right to Buy) | D | 21,00 | 249.998 | 249.998 | |||||
| 2021-01-07 | 3 | Michaelson Jennifer | CGEM | Common Stock | D | 22.911 | ||||||||
| 2021-01-07 | 3 | Rosenberg Anthony | CGEM | Common Stock | D | 45.002 | ||||||||
| 2021-01-07 | 3 | Ebeling Thomas | CGEM | Common Stock | D | 67.504 | ||||||||
| 2021-01-07 | 3 | Zawel Leigh | CGEM | Common Stock | D | 149.760 | ||||||||
| 2021-01-07 | 3 | GADICKE ANSBERT | CGEM | Common Stock | D | 281.268 | ||||||||
| 2021-01-07 | 3 | Baeuerle Patrick | CGEM | Common Stock | I | 341.434 | ||||||||
| 2021-01-07 | 3 | Keane Raymond T | CGEM | Common Stock | D | 1.624 | ||||||||
| 2021-01-07 | 3 | F2 MC, LLC | CGEM | Common Stock | D | 112.507 | ||||||||
| 2021-01-07 | 3 | Hughes Owen | CGEM | Common Stock | D | 503.726 | ||||||||
| 2021-01-07 | 3 | Savill Corrine | CGEM | Common Stock | D | 193.115 |
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
